![Kyle Piskel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 30/06/2026
Kyle Piskel is currently the Chief Financial & Accounting Officer at Adaptive Biotechnologies Corp., a position held since 2024.
The career at Adaptive Biotechnologies Corp.
began in 2015 and is ongoing.
Education includes an undergraduate degree from Eastern Washington University and a graduate degree from Gonzaga University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/05/2026 | 256.725 ( 0,16 % ) | 6 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director Financiero/CFO | 08/04/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Eastern Washington University
 Eastern Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gonzaga University
 Gonzaga University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
